AbstractThis experimental study was designed to assess the influence of failure of the right side of the heart or pulmonary hypertension, or both, on the performance of a novel miniaturized left ventricular assist device. In small-sized dogs ( n = 50) ischemic global left ventricular failure was induced and support was provided by the HIA-VAD displacement pump (stroke volume 10 or 25 ml) installed as a left ventricular assist device. In three groups of animals ( n = 10 each) pulmonary hypertension was created before induction of global left ventricular failure. During left ventricular assist device support temporary ischemic failure of the right side of the heart was induced in four groups of animals ( n = 10 each). In the group subjected t...
Pulmonary arterial hypertension (PAH) is caused by a pathological increase in pulmonary vascular res...
Pulmonary hypertension (PH) type II (classified by the World Health Organization) is a common compli...
For treatment of advanced heart failure, current strategies include cardiac transplantation or blood...
Objective: Right ventricular failure during left ventricular assist device (WAD) support can result ...
Background: In the long term, patients with univentricular hearts and high pulmonary artery pressure...
Recently much progress has been made in mechanical support of the failing heart, ventricular assist ...
AbstractObjectives: The purpose of this study was to investigate how the inflow cannulation site of ...
ObjectiveCurrent left ventricular assist devices are designed to provide full hemodynamic support fo...
ObjectiveControversy exists regarding the optimal pumping method for left ventricular assist devices...
During the development of a new circulatory support system, we have used different animal models wit...
Left ventricular assist device (LVAD) overpumping is associated with hemolysis, thrombus release, an...
ABSTRACT A significant fraction of patients in whom mechanical left ventricular assist devices are i...
Implantation of a left ventricular assist device (LVAD) is a potential treatment in terminal heart f...
Left ventricular assist device (LVAD) overpumping is associated with hemolysis, thrombus release, an...
Right ventricular failure after left ventricular assist device (LVAD) implantation is associated wit...
Pulmonary arterial hypertension (PAH) is caused by a pathological increase in pulmonary vascular res...
Pulmonary hypertension (PH) type II (classified by the World Health Organization) is a common compli...
For treatment of advanced heart failure, current strategies include cardiac transplantation or blood...
Objective: Right ventricular failure during left ventricular assist device (WAD) support can result ...
Background: In the long term, patients with univentricular hearts and high pulmonary artery pressure...
Recently much progress has been made in mechanical support of the failing heart, ventricular assist ...
AbstractObjectives: The purpose of this study was to investigate how the inflow cannulation site of ...
ObjectiveCurrent left ventricular assist devices are designed to provide full hemodynamic support fo...
ObjectiveControversy exists regarding the optimal pumping method for left ventricular assist devices...
During the development of a new circulatory support system, we have used different animal models wit...
Left ventricular assist device (LVAD) overpumping is associated with hemolysis, thrombus release, an...
ABSTRACT A significant fraction of patients in whom mechanical left ventricular assist devices are i...
Implantation of a left ventricular assist device (LVAD) is a potential treatment in terminal heart f...
Left ventricular assist device (LVAD) overpumping is associated with hemolysis, thrombus release, an...
Right ventricular failure after left ventricular assist device (LVAD) implantation is associated wit...
Pulmonary arterial hypertension (PAH) is caused by a pathological increase in pulmonary vascular res...
Pulmonary hypertension (PH) type II (classified by the World Health Organization) is a common compli...
For treatment of advanced heart failure, current strategies include cardiac transplantation or blood...